Persistence of racial and ethnic disparities in risk and survival for patients with neuroblastoma over two decades

Mohansrinivas Chennakesavalu,Caileigh Pudela,Mark A. Applebaum,Sang Mee Lee, Yan Che,Arlene Naranjo,Julie R. Park,Samuel L. Volchenboum,Tara O. Henderson,Susan L. Cohn,Ami V. Desai

EJC Paediatric Oncology（2023）

引用 0|浏览18

暂无评分

摘要

•Survival for patients with neuroblastoma has improved with advancement in treatment.•Racial/ethnic survival disparities persist in the current era (2010–2019).•Adjustment for risk group does not abrogate these disparities in the current era.•Survival disparities exist among those assigned to post-Consolidation dinutuximab.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要